Role of dopamine in the motivational and cognitive control of behavior

Neuroscientist

Volumn 14, Issue 4, 2008, Pages 381-395

  Cools, Roshan ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Cognitive flexibility; Dopamine; Impulsivity; Motivation; Punishment; Reward; Working memory

Indexed keywords

DOPAMINE;

AUTOREGULATION; COGNITION; DOPAMINERGIC TRANSMISSION; HUMAN; IMPULSIVENESS; LEARNING; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTIVATION; NEUROSCIENCE; PRIORITY JOURNAL; PUNISHMENT; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WORKING MEMORY;

ANIMALS; BEHAVIOR; BRAIN; BRAIN MAPPING; COGNITION; DOPAMINE; DOPAMINE AGENTS; HUMANS; MOTIVATION;

EID: 47549083266     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858408317009     Document Type: Review

References (93)

1. Akil M., Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE 2003. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23: 2008-13.
2. Alexander G., DeLong M., Stuck P. 1986. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357-81.
3. Apud JA, Mattay V., Chen J., Kolachana BS, Callicott JH, Rasetti R., and others. 2007. Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology 32: 1011-20.
4. Arnsten AFT, 1998. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2: 436-46.
5. Aron AR 2007. The neural basis of inhibition in cognitive control. Neuroscientist 13: 214-28.
6. Baldo BA, Kelley AE 2007. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 191: 439-59.
7. Berridge KC, Robinson TE 1998. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-69.
8. Bertolino A., Blasi G., Latorre V., Rubino V., Rampino A., Sinibaldi L., and others. 2006. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurocsci 26: 3918-22.
9. Bilder R., Volavka K., Lachman H., Grace A. 2004. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29: 1943-61.
10. Brozoski TJ, Brown R., Rosvold HE, Goldman PS 1979. Cognitive deficit caused by regional depletion of dopamine in the prefrontal cortex of rhesus monkeys. Science 205: 929-31.
11. Caldu X., Vendrell P., Bartres-Faz D., Clemente I., Bargallo N., Jurado MA, and others. 2007. Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 37: 1437-44.
12. Cardinal RN, Winstanley CA, Robbins TW, Everitt BJ 2004. Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci 1021: 33-50.
13. Chen J., Lipska B., Halim N., Ma Q., Martsumoto M., Melhem S., and others. 2004. Functional analysis of genetic variation in catechol-O- methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Genet 75: 807-21.
14. Clark L., Blackwell A., Aron A., Turner D., Dowson J., Robbins T., and others. 2007. Association between response inhibition and working memory in adult ADHD: a link to right frontal cortex pathology? Biol Psychiatry 61: 1395-401.
15. Cohen MX, Krohn-Grimberghe A., Elger CE, Weber B. 2007. Dopamine gene predicts the brain's response to dopaminergic drug. Eur J Neurosci 26: 3652-60.
16. Cohen MX, Young J., Baek JM, Kessler C., Ranganath C. 2005. Individual differences in extraversion and dopamine genetics predict neural reward responses. Brain Res Cogn Brain Res 25: 851-61.
17. Congdon E., Canli T. 2005. The endophenotype of impulsivity: reaching consilience through behavioral, genetic, and neuroimaging approaches. Behav Cogn Neurosci Rev 4: 262-81.
18. Cools AR 1980. Role of the neostriatal dopaminergic activity in sequencing and selecting behavioural strategies: facilitation of processes involved in selecting the best strategy in a stressful situation. Behav Brain Res 1: 361-78.
19. Cools AR, Van Den Bercken JHL, Horstink MWI, Van Spaendonck KPM, Berger HJC. 1984. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry 47: 443-53.
20. Cools R., Altamirano L., D'Esposito M. 2006. Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 44: 1663-1673.
21. Cools R., Blackwell A., Clark L., Menzies L., Cox S., Robbins TW 2005. Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 30: 1362-73.
22. Cools R., Gibbs S., Miyakawa A., Jagust W., D'Esposito M. 2008. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28: 1208-12.
23. Cools R., Robbins TW 2004. Chemistry of the adaptive mind. Philos Transact A Math Phys Eng Sci 362: 2871-88.
24. Cools R., Sheridan M., Jacobs E., D'Esposito M. 2007. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci 27: 5506-14.
25. Cooper J., Bloom F., Roth R. 2003. The biochemical basis of neuropharmacology, 8 Edition. Oxford: Oxford University Press.
26. Dalley JW, Fryer TD, Birchard L., Robinson ES, Theobald DE, Laane K., and others. 2007. Nucleus accumbens D2 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-70.
27. Dawe S., Loxton NJ 2004. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev 28: 343-51.
28. Durstewitz D., Seamans J., Sejnowski T. 2000. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 83: 1733-50.
29. Ernst M., Luckenbaugh DA, Moolchan ET, Leff MK, Allen R., Eshel N., and others. 2006 b. Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics 117: 2030-39.
30. Ernst M., Pine DS, Hardin M. 2006 a. Triadic model of the neurobiology of motivated behavior in adolescence. Psychol Med 36: 299-312.
31. Evenden J. 1999. Varieties of impulsivity. Psychopharmacology 146: 348-61.
32. Forbes EE, Brown SM, Kimak M., Ferrell RE, Manuck SB, Hariri AR 2007. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry (advance online publication, 25 September 2007). doi:10.1038/sj.mp.4002086.
33. Frank M., Loughry B., O'Reilly R. 2001. Interactions between frontal cortex and basal ganglia in working memory: a computational model. Cogn Affect Behav Neurosci 1: 137-60.
34. Frank MJ 2005. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated parkinsonism. J Cogn Neurosci 17: 51-72.
35. Frank MJ, Moustafa AA, Haughey HM, Curran T., Hutchison KE 2007. Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc Natl Acad Sci U S A 104: 16311-6.
36. Frank MJ, O'Reilly RC 2006. A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 120: 497-517.
37. Frank MJ, Seeberger LC, O'Reilly RC 2004. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306: 1940-3.
38. Gibbs SE, D'Esposito M. 2005. Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. Cogn Affect Behav Neurosci 5: 212-21.
39. Gray J. 1982. The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system. Oxford: Oxford University Press.
40. Gruber AJ, Dayan P., Gutkin BS, Solla SA 2006. Dopamine modulation in the basal ganglia locks the gate to working memory. J Comput Neurosci 20: 153-66.
41. Heinz A., Goldman D., Jones DW, Palmour R., Hommer D., Gorey JG, and others. 2000. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22: 133-9.
42. Hirvonen M., Laakso A., Nagren K., Rinne JO, Pohjalainen T., Hietala J. 2004. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9: 1060-1.
43. Hutchison KE, Wood M., Swift R. 1999. Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans. Exp Clin Psychopharmacol 7: 493-501.
44. Ikemoto S., Panksepp J. 1999. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 31: 6-41.
45. James A., Groman S., Seu E., Jorgensen M., Fairbanks L., Jentsch J. 2007. Dimensions of impulsivity are associated with poor spatial working memory performance in monkeys. J Neurosci 27: 14358-64.
46. Jentsch J., Taylor J. 1999. Impulsivity resulting from fronto-striatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146: 373-90.
47. Kimberg DY, D'Esposito M., Farah MJ 1997. Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8: 3581-5.
48. Kirsch P., Reuter M., Mier D., Lonsdorf T., Stark R., Gallhofer B., and others. 2006. Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett 405: 196-201.
49. Kish SJ, Shannak K., Hornykiewicz O. 1988. Uneven patterns of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. New Eng J Med 318: 876-880.
50. Klein TA, Neumann J., Reuter M., Hennig J., von Cramon DY, Ullsperger M. 2007. Genetically determined differences in learning from errors. Science 318: 1642-5.
51. Konorski J. 1967. Integrative activity of the brain: an interdisciplinary approach. Chicago: The University of Chicago.
52. Koob GF, Riley SJ, Smith SC, Robbins TW 1978. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat. J Comp Physiol Psychol 92: 917-27.
53. Laakso A., Pohjalainen T., Bergman J., Kajander J., Haaparanta M., Solin O., and others. 2005. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15: 387-91.
54. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., and others. 1995. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34: 4202-10.
55. Lyon M., Robbins TW 1975. The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essman W, editor. Current developments in psychopharmacology. New York: Spectrum.
56. Mattay V., Goldberg T., Fera F., Hariri A., Tessitore A., Egan M., and others. 2003. Catechol O-methyltransferase Val158 -met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-91.
57. McNab F., Klingberg T. 2008. Prefrontal cortex and basal ganglia control access to working memory. Nat Neurosci 11: 103-7.
58. Meyer-Lindenberg A., Kohn PD, Kolachana B., Kippenhan S., McInerney-Leo A., Nussbaum R., and others. 2005. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8: 594-6.
59. Meyer-Lindenberg A., Miletich RS, Kohn PD, Esposito G., Carson RE, Quarantelli M., and others. 2002. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5: 267-71.
60. Meyer-Lindenberg A., Straub RE, Lipska BK, Verchinski BA, Goldberg T., Callicott JH, and others. 2007. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 117: 672-82.
61. Mill J., Asherson P., Browes C., D'Souza U., Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114: 975-9.
62. Nolan K., Bilder R., Lachman H., Volavka K. 2004. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 161: 359-61.
63. Oades RD 1985. The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neurosci Biobehav Rev 9: 261-82.
64. Patton J., Stanford M., Barratt E. 1995. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51: 768-74.
65. Pessiglione M., Guehl D., Jan C., Francois C., Hirsch E., Feger J., Tremblay L. 2004. Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference. Eur J Neurosci 19: 437-46.
66. Pohjalainen T., Rinne JO, Nagren K., Lehikoinen P., Anttila K., Syvalahti EK, and others. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3: 256-60.
67. Potts GF, George MR, Martin LE, Barratt ES 2006. Reduced punishment sensitivity in neural systems of behavior monitoring in impulsive individuals. Neurosci Lett 397: 130-4.
68. Pycock CJ, Kerwin RW, Carter CJ 1980. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286: 74-7.
69. Reuter J., Raedler T., Rose M., Hand I., Glascher J., Buchel C. 2005. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8: 147-8.
70. Robbins TW, Cador M., Taylor JR, Everitt BJ 1989. Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev 13: 155-62.
71. Robbins TW, Everitt BJ 1992. Functions of dopamine in the dorsal and ventral striatum. Semin Neurosci 4: 119-27.
72. Robbins TW, Everitt BJ 2003. Motivation and reward. In: Squire L, Bloom F, McConnell S, Roberts J, Spitzer N, Zigmond M, editors. Fundamental neuroscience. 2 ed. London: Academic Press. p 1109-26.
73. Salamone JD, Correa M., Farrar A., Mingote SM 2007. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) 191: 461-82.
74. Sawaguchi T., Goldman-Rakic PS 1991. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251: 947-50.
75. Schultz W. 2000. Multiple reward signals in the brain. Nat Rev Neurosci 1: 199-207.
76. Torstenson R., Hartvig P., Langstrom B., Bastami S., Antoni G., Tedroff J. 1998. Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone. Neuropharmacology 37: 989-95.
77. van den Bos R., Cools A. 2003. Switching to cue-directed behavior: specific for ventral striatal dopamine but not ventral pallidum/substantia innominata gaba as revealed by a swimming-test procedure in rats. Neuroscience 118: 1141-9.
78. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M., and others. 2005. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46: 745-51.
79. VanNess SH, Owens MJ, Kilts CD 2005. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 6: 55.
80. van Oosten RV, Cools AR 2002. Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty. Exp Neurol 173: 245-55.
81. van Oosten RV, Verheij MM, Cools AR 2005. Bilateral nigral 6-hydroxydopamine lesions increase the amount of extracellular dopamine in the nucleus accumbens. Exp Neurol 191: 24-32.
82. Verdejo-Garcia A., Lawrence A., Clark L. In press. Impulsivity as a vulnerability marker for substance use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neuroci Biobehav Rev.
83. Vijayraghavan S., Wang M., Birnbaum S., Williams G., Arnsten A. 2007. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10: 176-84.
84. Volkow N., Wang G., Fowler J., Logan J., Gatley S., Gifford A., and others. 1999. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 156: 1440-3.
85. Volkow ND, Wang GJ, Fowler JS, Logan J., Gatley SJ, Hitzemann R., and others. 1997. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-3.
86. Voon V., Potenza M., Thomsen T. 2007. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 20: 484-92.
87. Wallace J., Newman J. 1990. Differential effects of reward and punishment cues on response speed in anxious and impulsive individuals. Person Indiv Diff 11: 999.
88. Wang Y., Goldman-Rakic P. 2004. D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons. Proc Natl Acad Sci U S A 101: 5093-8.
89. Williams GV, Goldman-Rakic PS 1995. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 572-5.
90. Winstanley CA 2007. The orbitofrontal cortex, impulsivity, and addiction: probing orbitofrontal dysfunction at the neural, neurochemical, and molecular level. Ann N Y Acad Sci 1121: 639-55.
91. Yacubian J., Sommer T., Schroeder K., Glascher J., Kalisch R., Leuenberger B., and others. 2007. Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci U S A 104: 8125-30.
92. Zahrt J., Taylor JR, Mathew RG, Arnsten AFT. 1997. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528-35.
93. Zhang Y., Bertolino A., Fazio L., Blasi G., Rampino A., Romano R., and others. 2007. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104: 20552-7.